Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a smartphone app help you kick the habit?

NCT ID NCT05763771

Symptom relief Sponsor: M.D. Anderson Cancer Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Aug 11, 2026 · Updated 3 times

Summary

This study is testing whether a smartphone app, combined with nicotine patches, can help people reduce or quit smoking. The app guides users to smoke on a schedule and tracks their progress. The study involves 56 adult smokers who smoke at least 10 cigarettes a day. The goal is to see if the app is easy to use and if it helps people quit.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Nicotine patches
What this could lead to
If successful, this could provide a new, convenient tool to help people quit smoking.
What could go wrong
This is a small feasibility study, not a large trial. The app may not be effective for everyone, and results may not apply to the general population.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

56 people

The number who actually took part.

Started

Feb 2024

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Age: 18 years old or older * Smoking: an average of 10 or more cigarettes, little cigars, or cigarillos combined per day within the past 30 days preceding the phone screen * Expired carbon monoxide (CO): \> 6 ppm * Can install and run the study app on their Android smartphone, or agree to use the study smartphone loaned from the research team * Agree to return the study smartphone if the participant loans one from the research team * Willing to reduce smoking (Aim 1) * Seeking smoking cessation treatment (Aim 2) * Fluency in spoken and written English * Agree to be treated via telehealth (live audio-video conference and phone) and to be contacted via text and/or email * Provide informed consent and agree to all assessments and study procedures * Willing to refrain from the use of other nicotine/tobacco products for the duration of the study * Willing to refrain from the use of marijuana, prescription medications not prescribed to the participant, and illegal drugs Exclusion Criteria: * Taking psychotropic, anticonvulsive, or narcotic medication * Meet criteria for a current major depressive episode or suicidality according to the PHQ (indicated by a score of 10 or higher). * Involved in current and imminent (within the next 45 days) smoking cessation activity * Women who are pregnant or breastfeeding * Shares the same address as a currently enrolled participant * Unwilling to use or allergic to nicotine patches (Aim 2) * Considered by the investigator to be an unsuitable or unstable candidate, such as those who appear to have cognitive impairment, and those who reside in a shelter, group/recovery facility, or treatment facility * Any plans to move out of the state in the next 6 months * Using marijuana, prescription medications not prescribed to the participant, and illegal drugs on a daily basis * Have experienced abnormal heart rhythms or cardiovascular disease, such as stroke, chest pain, and heart attack, in the last month (Aim 2)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Smoking are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

nicotine dependence Smoking

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Smoking

Contacts and locations

Locations

  • M D Anderson Cancer Center

    Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.